Literature DB >> 903380

Selective lethal effect of thymidine on human and mouse tumor cells.

S S Lee, B C Giovanella, J S Stehlin.   

Abstract

Human cell lines derived from a melanoma and a colon carcinoma, and cultures of human melanocytes and intestinal epithelial cells, as well as a mouse mesenchymal non-neoplastic cell line and a malignant subline of the same have been quantitatively studied in tissue culture for their sensitivity to thymidine. All three tumor lines produced solid tumors when injected into nude thymus-deficient mice. No tumors were obtained by injecting cells of the human normal long-term cultures or the non-neoplastic mouse line. The tumor-producing lines showed a greater sensitivity to the lethal effects of high concentrations of thymidine than their non-tumor-producing counterparts. Less than 23% of the tumor cells survived 72 hours in the presence of 1 mg/ml of thymidine, in contrast to 60% or more of the non-tumor cells. Colony formation was much more inhibited by thymidine and the differential between normal and tumor cells was even more pronounced. Tumor cells which also were treated for 72 hours with 1 mg/ml of thymidine and then plated in fresh medium formed very few colonies. If the plating efficiency of the untreated controls is considered as 100%, 4.3% or less of the treated tumor cells formed colonies, in contrast to 33% or more of the non-tumor cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903380     DOI: 10.1002/jcp.1040920308

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.

Authors:  W J Moriconi; M Slavik; S Taylor
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

2.  Reversion of bacteriophage T4rII mutants by high levels of pyrimidine deoxyribonucleosides.

Authors:  J K DeVries; S S Wallace
Journal:  Mol Gen Genet       Date:  1982

Review 3.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.

Authors:  J D Cohen; H I Robins; M J Javid
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

5.  Selective antiproliferative effects of thymidine.

Authors:  S O Ooi; K Y Sim; M C Chung; O L Kon
Journal:  Experientia       Date:  1993-07-05

6.  Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.

Authors:  K Bhalla; S Grant
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 7.  Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.

Authors:  P H Ellims
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

8.  Alternative metabolic fates of thymine nucleotides in human cells.

Authors:  M R Taheri; R G Wickremasinghe; A V Hoffbrand
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

9.  Differential arginine dependence and the selective cytotoxic effects of activated macrophages for malignant cells in vitro.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.